The content centers on “Enterprise Taxonomy” related to telehealth, focusing on patient access for rural and underserved communities, as well as population and public health. It includes a note to exclude this information from the Accelerate RSS feed.
AstraZeneca Licenses Global Rights to Dizal Lung Cancer Drug for Up-to-$1.5B
AstraZeneca has acquired exclusive global rights to develop and commercialize Dizal Pharmaceutical’s marketed lung cancer drug Zegfrovy® (sunvozertinib), through an agreement that could generate up to
